Brand name: Glucose (B Braun) TM
Active ingredients: glucose
What it is used for
For intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. May also be used as solvents for intravenously administered drugs where compatibility has been established.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Intravenous
- Store below 25 degrees Celsius
- Lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Clear, colourless solution practically free of particles
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist. This medicine is Not Scheduled.
Is this medicine subsidised?
This medicine may be subsidised which may make it cheaper. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)
Need more information?
These trusted information partners have more on this topic.
Top results
Vitamin B
Vitamins naturally occur in food and are needed in very small amounts for various bodily functions such as energy production and making red blood cells. There are 13 vitamins that our body needs, eight of which make up the B-group (or B-complex) vitamins.
Read more on Better Health Channel website
Glucose - Lab Tests Online AU
Describes how the blood glucose test is used, when the glucose test is requested, and what the results of tests might mean.
Read more on Lab Tests Online website
Blood glucose monitoring
Self-blood glucose monitoring is a valuable diabetes management tool, which enables people to check their own blood glucose levels as often as they need to or as recommended.
Read more on WA Health website
Hypoglycaemia (low blood glucose) management
Hypoglycaemia occurs when your blood glucose levels are too low (less than 4.0mmol/l).
Read more on Baker Heart and Diabetes Institute website
Blood Glucose Control (Blood Sugar Levels) | myVMC
Our blood glucose level, or blood sugar level,is the amount of glucose in the blood. Glucose levels are measured most commonly to diagnose or to monitor diabetes. It is also important to keep an eye on blood glucose levels during certain situations, such aspregnancy, pancreatitis and increasing age.
Read more on myVMC – Virtual Medical Centre website
Better Blood Glucose Management - Glycemic Index Foundation
Studies around the world show that following a low GI diet significantly helps people with diabetes improve their blood glucose levels.
Read more on Glycemic Index Foundation website
Plasma-Lyte 148 and 5% Glucose IV Infusion - myDr.com.au
Plasma-Lyte 148 and 5% Glucose IV Infusion - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Compound Sodium Lactate (Hartmann's Solution) and 5% Glucose Solution for infusion - myDr.com.au
Compound Sodium Lactate (Hartmann's Solution) and 5% Glucose Solution for infusion - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Glucose Injection (Solution for injection) - myDr.com.au
Glucose Injection (Solution for injection) - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Hypoglycaemia - Diabetes NSW - Live your life
Hypoglycaemia is a low blood glucose level. It is also known as a hypo, insulin reaction or low blood glucose. We cover causes, signs and symptoms of hypoglycaemia, as well as treatments and explain what Glucagon is.
Read more on Diabetes NSW website
Top results
Continuous glucose monitoring systems for type 1 diabetes mellitus | Cochrane
Type 1 diabetes is a disease in which the pancreas has lost its ability to make insulin. A deficit in insulin leads to increases in blood glucose levels, these elevated blood glucose levels can lead to complications which may affect the eyes, kidneys, nerves and the heart and blood vessels. Since there is no cure for type 1 diabetes, patients need to check their blood glucose levels often by fingerprick and use these blood glucose values to decide on their insulin dosages. Fingerpricks are often regarded as cumbersome and uncomfortable by patients. In addition, fingerprick measurements only provide information about a single point in time, so it is difficult to discern trends in decline of rises in blood glucose levels.
Read more on Cochrane (Australasian Centre) website
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin | Cochrane
Self-monitoring of blood glucose has been found to be effective as a tool in the self-management of patients' glucose levels in people with type 1 diabetes and people with type 2 diabetes using insulin therapy. Patients can use the glucose values to adjust their insulin doses. It is hypothesized that patients with type 2 diabetes who are not using insulin might use the glucose values to adjust their diet and 'lifestyle'. However, there is no consensus on the effect of self-monitoring of blood glucose for type 2 diabetes patients not using insulin. In this systematic review update six new randomised controlled trials were added to the six trials that had been included in the original review. For the comparison of the effect of self-monitoring versus no self-monitoring in patients with a diabetes duration of one year or more 2324 patients with a six months follow-up and 493 patients with a 12 months follow-up were available. Pooled results of studies including patients diagnosed with type 2 diabetes for at least one year show that self-monitoring of blood glucose has a minimal effect in improving glucose control at six months, which disappears after 12 months follow-up. The clinical benefit resulting from this effect is limited.
Read more on Cochrane (Australasian Centre) website
Diabetes Insulin | Australian Sports Anti-doping Authority - ASADA
Diabetes mellitus is a long-term endocrine disorder, characterised by high blood glucose levels resulting from absolute or relative insulin deficiency. Diagnosis can be made at any age.Status of medication in sportInsulin is prohibited both in-and out-of-competition. (Note: Oral antidiabetics such as metformin are NOT prohibited)
Read more on Australian Sports Anti-Doping Authority (ASADA) website
Intermediate acting versus long acting insulin for type 1 diabetes mellitus | Cochrane
Diabetes mellitus type 1 is a chronic disease with short and long term complications. The treatment for this disease is insulin administration, with basal and bolus insulin preparations being its main stay. Neutral Protamine Hagedorn (NPH) insulin had previously been considered the standard of care for basal insulin replacement in blood glucose lowering for people with type 1 diabetes mellitus. Over the years, newer and longer acting insulins with a more physiological action profile became available: insulin ultralente, and later insulin glargine and insulin detemir. Their theoretical advantages lead to the thought of a beneficial effect on glucose level and rate of complications, such as very low levels of glucose or long term complications. The aim of this review was to assess whether this theoretical advantage is translated into real-life benefits, by comparing the effect of long acting insulins to intermediate acting insulins on diabetes control.
Read more on Cochrane (Australasian Centre) website
Exercise or exercise and diet for preventing type 2 diabetes mellitus | Cochrane
Type 2 diabetes is mainly characterised by a reduced ability of the hormone insulin to stimulate glucose uptake in body fat and muscles (insulin resistance) combined with insufficient insulin secretion that leads toincreased blood glucose levels. It has been shown that weight reduction and an increase in daily energy expenditure decreases insulin resistance. There are some factors that are associated with an increased risk of type 2 diabetes: these are obesity, previous gestational diabetes, hypertension, family history of type 2 diabetes, dyslipidaemia and some ethnical groups are more at risk. Persons with "prediabetes" are also at high risk: they have abnormal blood glucose levels but not in the range of diabetes. Prediabetes often precedes the development of type 2 diabetes. We searched for trials that intended to prevent the development diabetes type 2 in the above mentioned at risk groups. We assessed the effects of increased physical activity alone or in combination with dietary interventions on diabetes incidence and other outcomes.
Read more on Cochrane (Australasian Centre) website
Controlling high blood sugar levels with insulin in people who have had an acute ischaemic stroke | Cochrane
After a stroke, people with high levels of sugar in their blood have increased mortality regardless of their age, how severe the stroke was, or what type of stroke they had. Insulin can reduce blood sugar levels. We do not know what the optimal level of blood sugar should be after a stroke. We searched for trials that compared usual care with intensive insulin treatment (trying to keep blood sugar levels within the normal range of 4 to 7.5 mmol/L) after stroke. We found 11 trials involving 1583 participants. Trying to keep the blood sugar level within a tight range immediately after a stroke did not improve the outcomes of neurological deficit and dependency. It did, however, significantly increase the chance of experiencing very low blood sugar levels (hypoglycaemia), which can be harmful and can cause brain damage and death. On balance, the trials did not show any benefit from intensive control of blood sugar levels after stroke.
Read more on Cochrane (Australasian Centre) website
Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus | Cochrane
Short acting insulin analogues (Lispro, Aspart, Glulisine) act more quickly than regular human insulin. It can be injected immediately before meals and leads to lower blood sugar levels after food intake. Our analysis showed that short acting insulin analogues were almost identically effective to regular human insulin in long term glycaemic control and were associated with similar episodes of low blood sugar (hypoglycaemia). No information on late complications such as problems with the eyes, kidneys or feet are existing. Until long term safety data are available we suggest a cautious response to the vigorous promotion of insulin analogues.
Read more on Cochrane (Australasian Centre) website
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes | Cochrane
Read more on Cochrane (Australasian Centre) website
Short-acting insulin analogues versus regular human insulin for type 1 diabetes mellitus | Cochrane
Are short-acting insulin analogues more useful than regular human insulin for adults with type 1 diabetes?
Read more on Cochrane (Australasian Centre) website
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus | Cochrane
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus
Read more on Cochrane (Australasian Centre) website
